Owing to its IMAO properties, (-) selegiline hydrochloride may act on prolactin secretion. In the absence of specific studies, it is recommended that Selgian® should not be administered to pregnant and lactating bitches.

Selgian® should not be administered from the day before until the day after anaesthesia or tranquillisation performed with an alpha-2 agonist.

Do not administer with other alpha-2 agonists.

Selgian® should not be administered concomitantly with pethidine, fluoxetine or phenothiazines. The narcotic action of morphine is potentiated by Selgian®.

Emotional disorders can mask hierarchical conflicts. In dominant dogs suffering from an emotional disorder, the alleviation of the disorder can sometimes reveal a latent aggressiveness. In such cases, behavioural therapy must be instituted.

It is recommended to stop the treatment during pregnancy and lactation.

If no clinical improvement is observed after 2 months, continuing the treatment is unlikely to provide any further benefit. It is advisable to weigh animals before dosing to ensure the correct mg/kg dosage is administered.

In the event of accidental ingestion, seek medical advice and show the doctor the package leaflet. Wash hands after use.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

For animal treatment only. Keep out of reach and sight of children.